Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Find out which is better for you: cash back or reward points. Make smart financial choices that suit your lifestyle today!
27,078 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A once-celebrated treasure hunter exits federal custody after a decade behind bars, as investors weigh the legal fall...
A big stock move and a buyout rumor are reshaping how traders view NCR Atleos. A large block sale drew attention, jus...
XRP is stuck in a narrow band around $1.30-$1.38 as a rare bottom signal emerges. On-chain data hints at potential re...
If SpaceX goes public and one founder keeps the voting keys, what does that mean for ordinary investors? This guide b...
Ethereum is weighing a protocol-level shift that could divert staking rewards toward ecosystem development. The plan ...
NVIDIA’s new alliance with Meta Platforms tightens the AI infrastructure backbone, pushing AMD to the back foot as in...
CEOs confront a defining moment as AI and rapid tech adoption reshape how growth and work interact. This report outli...
United Airlines is moving its most valuable loyalty perks behind cardholder status, a change that could reshape the e...
A dramatic intraday rise in The Trade Desk shares grabbed headlines. This article breaks down the catalysts, what the...
A single hedge fund exit can move a stock as much as a major earnings beat. This guide breaks down a $34 million TDS ...